Kyverna Therapeutics, Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

3.330

-0.100 (-2.92%)

At close: Jan 17, 2025, 4:00 PM

3.360

+0.030 (0.90%)

After-hours: Jan 17, 2025, 7:48 PM EST

Kyverna Therapeutics Employees

Kyverna Therapeutics had 96 employees as of December 31, 2023.

Employees

96

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$1,152,656

Market Cap

143.76M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	96	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	122,000
Abbott Laboratories	114,000
AstraZeneca	89,900
Novartis AG	76,057
Merck & Co.	72,000
Novo Nordisk	64,319

Employee Rankings

KYTX News

15 hours ago - The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics, Inc. - Accesswire
1 day ago - Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
3 days ago - Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire
4 days ago - The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics Inc. - Accesswire
4 days ago - Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights - KYTX - PRNewsWire
5 days ago - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - PRNewsWire
6 days ago - The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics Inc - Accesswire
7 days ago - Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire